Oxford Cannabinoid Technologies Holdings Plc (OCTP.L)

0.3590 -0.0060 (-1.64%) As of 02:07PM BST. Market open.

Oxford Cannabinoid Technologies Holdings Plc

Prama House
267 Banbury Road
Oxford OX2 7HT
United Kingdom
44 20 3034 2820
https://www.oxcantech.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 7

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Clarissa Ann Sowemimo-Coker	CEO & Executive Director	215.67k	N/A	1980
Mr. Paul William Smalley	Finance Director & Executive Director	155.16k	N/A	1973
Mr. Indraneil Mahapatra	Co-Founder & Non-Executive Director	249.52k	N/A	1980
Dr. Valentino Parravicini	Chief Scientific Officer	N/A	N/A	1969
Mr. Robin Bennett	General Counsel & Company Secretary	N/A	N/A	N/A
Dr. Timothy Henry Corn FFPM, M.Sc.	Executive Director & Chief Medical Officer	N/A	N/A	1951

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate consists of OCT461201, an CB2 receptor, that is in phase – I clinical trial for use in the treatment of chemotherapy-induced peripheral neuropathy and irritable bowel syndrome (IBS), as well as in neuropathic and visceral pain conditions. The company is also developing OCT130401, which is in pre-clinical development for the treatment of trigeminal neuralgia. In addition, its development pipeline includes cannabinoid derivative products comprising OCT960609, a dual CB1 and CB2 agonist targeting an undisclosed neuropathic pain indications; and immunotherapy agents for the treatment of solid tumours. Oxford Cannabinoid Technologies Holdings Plc was incorporated in 2017 and is headquartered in London, the United Kingdom.

Corporate governance

Oxford Cannabinoid Technologies Holdings Plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.